Skip to main content
Premium Trial:

Request an Annual Quote

ABI, Hitachi Renew Pact to Develop, Sell CE-Based DNA Sequencers

NEW YORK, Jan. 5 (GenomeWeb News) - Applied Biosystems and Hitachi High-Technologies Corporation have renewed and amended a 1997 alliance to co-develop and commercialize capillary electrophoresis-based DNA-analysis technologies, ABI said today.

Terms of the agreement call for the companies to continue to be exclusive collaborators in the development and commercialization of CE-based instruments for research, applied market, and diagnostic applications. The current product line includes ABI's 3130 and 3730 DNA analyzers.


Katsuji Yamashita, senior vice president of Hitachi High-Technologies, said  his company "will also continue to develop new technologies to serve future demands of the genetic analysis market."


Financial terms of the agreement were not disclosed.


It was not immediately clear how the collaboration was amended. Calls to ABI and Hitachi High-Technologies' USaffiliate, which are both based in California, were not immediately returned.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more